XSHE
000950
Market cap1.29bUSD
Jul 10, Last price
5.18CNY
1D
1.97%
1Q
-14.80%
Jan 2017
-44.72%
Name
C.Q. Pharmaceutical Holding Co Ltd
Chart & Performance
P/E
23.15
P/S
0.11
EPS
0.22
Div Yield, %
0.59%
Shrs. gr., 5y
0.28%
Rev. gr., 5y
5.69%
Revenues
82.45b
+2.34%
Net income
387m
+36.65%
CFO
755m
P
Dividend
Jan 16, 20260.03 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
C.Q. Pharmaceutical Holding Co., Ltd. is a pharmaceutical company primarily involved in the development, manufacturing, and distribution of medicinal products. Established in 1950, the firm has its headquarters in Chongqing, China. Its historical lineage includes Chongqing Medicines Co., Ltd., which was previously known as the Southwest Branch of China Medicine Company. C.Q. Pharmaceutical Holding Co., Ltd. operates as a subsidiary of Chongqing Chemical & Pharmaceutical Holding Group Company.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||